Compare ImmunityBio Inc. Common Stock (IBRX) vs Keel Infrastructure Corp. Common Stock (KEEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Keel Infrastructure Corp. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Keel Infrastructure Corp. Common Stock trades at $3.22 (market cap $2.06B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 5× Keel Infrastructure Corp. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Keel Infrastructure Corp. Common Stock for 0 Days on average.
| IBRX | KEEL | |
|---|---|---|
Market Cap | $10.33B | $2.06B |
Volume | 11,745,198 | 26,532,713 |
Sector | Health | Technology |
52-Week High | $11.55 | $6.66 |
52-Week Low | $1.98 | $1.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $2.38B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →
